Welsh, J. W., Tang, C., de Groot, P., Naing, A., Hess, K. R., Heymach, J. V., . . . Hong, D. S. (2019). Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses. Cancer Immunol Res.
Citação norma ChicagoWelsh, James W., et al. "Phase II Trial of Ipilimumab With Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses." Cancer Immunol Res 2019.
MLA CitationWelsh, James W., et al. "Phase II Trial of Ipilimumab With Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses." Cancer Immunol Res 2019.